Genexine: Genexine completes BLA submission for anemia treatment

Genexine said it has completed the biologics license application (BLA) to the Ministry of Food and Drug Safety (MFDS) for Efesa (efepoetin alfa), its anemia treatment.Developed in collaboration with Kalbe through their joint venture, KGBio, Efesa is a third-generation treatment for renal anemia.Unli